The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims to establish the feasibility and acceptability of a project designed to investigate the impact of electronic cigarette use on combustible cigarette smoking and smoking-related factors among smokers with psychiatric disorders, a high-risk population, who are not yet ready to quit smoking. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedStudy Start
First participant enrolled
December 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedSeptember 18, 2023
September 1, 2023
3.7 years
July 8, 2019
September 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes in the number of combustible cigarettes smoked per day
The average number of cigarettes smoked per day
Baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks
Changes in Carbon Monoxide Level
Changes in Carbon monoxide level measured with a breath carbon monoxide monitor
Baseline,2 weeks, 4 weeks, 8 weeks, 12 weeks
Changes in Nicotine Dependence
Fagerstrom Test of Cigarette Dependence
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Changes in the use of e-cigarettes
Changes in the use of e-cigarettes
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Rates of those who completely switched to e-cigarettes
Rates of those who completely switched to e-cigarettes
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Secondary Outcomes (2)
Changes in Motivation/Readiness to Quit Smoking
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Changes in Withdrawal Symptoms
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Study Arms (1)
E-cigarette
EXPERIMENTALAll participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.
Interventions
All participants will be provided with 8 weeks of e-cigarettes at no cost based on self-report of regular cigarette use. All participants will receive a total of 8-10 remote counseling sessions (via phone or video conference) and during which they will discuss ways to switch from smoking cigarettes to exclusively using e-cigarettes, barriers and strategies to overcome them. (All participants will receive sessions at baseline, 2 days, 7 days, 2 weeks, 3 weeks, and 4 weeks, 6 weeks , and 8 weeks after the baseline assessment. Two additional sessions at 5 weeks and 7 weeks (after the baseline assessment) will be provided to those who are still smoking combustible cigarettes at 4-week assessment.)
Eligibility Criteria
You may qualify if:
- years of age or older
- English-speaking,
- current daily smokers (i.e., at least 5 cigarettes/day)
- have been daily smokers at least for 6 months
- attended a minimum of 2 treatment visits in the past 12 months at Montefiore Behavioral Health Center
- have at least one psychiatric disorder (other than substance use disorders),
- willing to try switching to use e-cigarettes (provided by the research team) exclusively for a total of 8 weeks,
- those who are not yet ready to quit smoking,
- for women of childbearing age, willingness to use contraception during the study.
You may not qualify if:
- acute psychiatric symptomatology which precludes study participation including current active suicidal ideation
- current diagnosis of dementia or cognitive impairment sufficient to impair provision of informed consent or study participation
- patient's inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures as contained in the statement of informed consent, after no more than two explanations
- current clinical diagnosis of intellectual development disorder
- current regular use of other tobacco products or combustible marijuana
- current (non-nicotine) substance use disorder and current substance use (in the past month)
- current effort to quit smoking or current use of pharmacotherapy (in the past month) to quit smoking,
- pregnant, breastfeeding, or planning to become pregnant within 6 months, current unstable cardiovascular disease,
- current unstable pulmonary disease (i.e., an ER visit or hospitalization due to pulmonary issues in the past 6 month or current use of oxygen therapy),
- patient does not have a stable home address where the research team could reliably reach patient
- household members are currently participating or have participated in this research study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fordham Universitylead
- Montefiore Medical Centercollaborator
- Dartmouth Collegecollaborator
Study Sites (1)
Montefiore Behavioral Health Center
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Haruka Minami, Ph.D.
Fordham University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2019
First Posted
July 10, 2019
Study Start
December 12, 2020
Primary Completion
September 1, 2024
Study Completion
December 1, 2024
Last Updated
September 18, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share